Literature DB >> 7433485

Tolerance to suppressive effects of chlordiazepoxide on operant behavior: lack of cross tolerance to pentobarbital.

D A Cesare, J W McKearney.   

Abstract

Pigeons responded under schedules in which either the 60th response (fixed-ratio schedule) or the first response after 3 minutes (fixed-interval schedule) resulted in food delivery. The effects of chlordiazepoxide HCl (1-30 mg/kg) and pentobarbital sodium (1-17 mg/kg) were determined before and during chronic daily exposure to either 10 or 17 mg/kg chlordiazepoxide--doses that markedly suppressed responding when given acutely. After about three weeks of daily injections of chlordiazepoxide, there was at least a three-fold shift to the right of the dose-effect curve for chlordiazepoxide, but not consistent change in the effects of pentobarbital.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7433485     DOI: 10.1016/0091-3057(80)90278-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Chronic diazepam administration and appetitive discrimination learning: acquisition versus steady-state performance in pigeons.

Authors:  L M Hughes; E A Wasserman; J V Hinrichs
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Selective changes in sensitivity to benzodiazepines, and not other positive GABA(A) modulators, in rats receiving flunitrazepam chronically.

Authors:  Lisa R Gerak
Journal:  Psychopharmacology (Berl)       Date:  2009-03-10       Impact factor: 4.530

3.  Overlapping, but not identical, discriminative stimulus effects of the neuroactive steroid pregnanolone and ethanol.

Authors:  Lisa R Gerak; Joseph M Moerschbaecher; Peter J Winsauer
Journal:  Pharmacol Biochem Behav       Date:  2008-02-11       Impact factor: 3.533

4.  Acute cross tolerance to midazolam, and not pentobarbital and pregnanolone, after a single dose of chlordiazepoxide in monkeys discriminating midazolam.

Authors:  Lisa R Gerak; Lance R McMahon; Charles P France
Journal:  Behav Pharmacol       Date:  2008-12       Impact factor: 2.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.